Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Celgene wins FDA approval to expand Vidaza label
This expanded indication supplements the 2004 FDA authorization of Vidaza as the first therapy approved in the US for the treatment of patients with all five French American
This expanded indication supplements the 2004 FDA authorization of Vidaza as the first therapy approved in the US for the treatment of patients with all five French American
The company received FDA and Health Canada approval for the clinical trial earlier in 2008. The Phase II trial will be an international, multi-center, randomized, controlled, open-label study
If approved for an imaging indication, ferumoxytol could offer an alternative to gadolinium-based contrast agents, which are required to contain a black box warning highlighting the risks of
Ms Mulligan succeeds Adrian Saldanha, who had been serving as Biovail’s interim CFO. Ms Mulligan was most recently a principal at Priiva Consulting, a game theory consulting practice.
The randomized, double-blind, placebo-controlled Phase III study is evaluating Nexavar (sorafenib) tablets as adjuvant treatment, which is treatment following surgery or local radiation, for patients with hepatocellular carcinoma
Generex said that Glucose RapidSpray is an alternative for people who want additional glucose in their diet. It is reported that Glucose RapidSpray delivers a fat-free, low-calorie glucose
This Phase I, randomized, double-blind, placebo-controlled trial will evaluate the safety, tolerability, pharmacokinetics and uric acid lowering effects of single ascending oral doses of RDEA594 in healthy adult
Net earnings for the first quarter of fiscal year 2009 were $747 million, or $0.66 per diluted share, an increase of 11% and 12%, respectively, over the same
In this role, Mr Gonze will oversee Averion’s global business development and marketing activities, and will serve on the company’s executive management team. For the past six years
The shares were purchased by certain private investors on August 19, 2008. The shares were sold in a company managed private investment in public equity transaction at a